Ownership history in BROOKTREE CAPITAL MANAGEMENT · 16 quarters on record
This page tracks every 13F SEC filing in which BROOKTREE CAPITAL MANAGEMENT reported a position in WEST PHARMACEUTICAL SVSC INC (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 5,159 | -140 | -2.6% | 0.94% | $1.4M | $274.89 |
| 2025 Q3 | ADDED | 5,299 | +374 | +7.6% | 0.88% | $1.4M | $261.88 |
| 2025 Q2 | ADDED | 4,925 | +185 | +3.9% | 0.70% | $1.1M | $218.25 |
| 2025 Q1 | ADDED | 4,740 | +154 | +3.4% | 0.80% | $1.1M | $223.09 |
| 2024 Q4 | REDUCED | 4,586 | -18 | -0.4% | 1.11% | $1.5M | $326.20 |
| 2024 Q3 | ADDED | 4,604 | +139 | +3.1% | 1.12% | $1.4M | $298.72 |
| 2024 Q2 | REDUCED | 4,465 | -198 | -4.2% | 1.26% | $1.5M | $327.59 |
| 2024 Q1 | ADDED | 4,663 | +187 | +4.2% | 1.42% | $1.8M | $393.34 |
| 2023 Q4 | REDUCED | 4,476 | -265 | -5.6% | 1.27% | $1.6M | $349.82 |
| 2023 Q3 | ADDED | 4,741 | +141 | +3.1% | 1.49% | $1.8M | $372.54 |
As of 2025 Q4 — sorted by position size